Providence Capital Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Providence Capital Advisors's MDT Position: Q2 2026 in Review
Providence Capital Advisors increased its Medtronic (MDT) stake by 31% in Q2 2026, buying an estimated $1.86M and bringing the position to 97,100 shares worth $7.6M. The position accounts for 1.15% of the portfolio, ranked #30.
Providence Capital Advisors first reported a position in MDT in Q4 2017 and has held it in 23 quarters since. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Providence Capital Advisors held 97,100 shares of Medtronic worth $7.6M as of Q2 2026.
- Providence Capital Advisors bought 23,100 Medtronic shares in Q2 2026, an estimated $1.86M.
- Medtronic made up 1.15% of Providence Capital Advisors's portfolio in Q2 2026, its #30 holding.
- Providence Capital Advisors first reported a position in Medtronic in Q4 2017 and has held it in 23 quarters since.
- 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Providence Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.